Cybin to Acquire Small Pharma Inc.
Cybin to acquire Small Pharma creating an international clinical-stage leader in novel psychedelic therapeutics.
Small Pharma Reports Fiscal First Quarter 2024 Highlights
Financial highlights and recent business and R&D highlights.
Small Pharma Reports Financial Results for Fiscal Year End and Recent Business Highlights
Multiple clinical milestones achieved with operational efficiencies underway.
Small Pharma To Participate In November Investor And Healthcare Conferences
Small Pharma to participate in Jefferies Conference and CNS Summit.
Small Pharma Reports Fiscal Second Quarter 2023 Highlights
Second quarter 2023 highlights including last patient dosed.
Small Pharma Enters Into Automatic Share Purchase Plan
The ASPP has been approved by the TSX Venture Exchange.
Small Pharma Announces TSXV Approval of Normal Course Issuer Bid
The TSX Venture Exchange has accepted Small Pharma's application.
Small Pharma Reports Fiscal First Quarter 2023 Highlights
Progress continues with multiple trials expected to enter clinic later this year.
Small Pharma Reports Highlights for the Fiscal Year Ended February 28, 2022
Small Pharma reports highlights for the fiscal year ended February 2022.
Small Pharma Shares Business Update Ahead of Annual Financial Results
Small Pharma shares business update ahead of annual financial results, including a new COO appointment.